The effect of prior docetaxel (DOC) treatment on efficacy and safety of apalutamide (APA) plus androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) from TITAN.
Date
2022Author
Given, Robert
Chi, Kim N.
Merseburger, Axel S.
Ozguroglu, Mustafa
Chowdhury, Simon
Bjartell, Anders
Chung, Byung
Gomes, Andrea Juliana Pereira de Santana
Juarez, Alvaro
Uemura, Hirotsugu
Ye, Dingwei
Karsh, Lawrence Ivan
Gartrell, Benjamin Adam
Brookman-May, Sabine D.
Mundle, Suneel
McCarthy, Sharon Anne
Lefresne, Florence
Rooney, Oliver Brendan
Bhaumik, Amitabha
Agarwal, Neeraj
Metadata
Show full item recordCollections
- Makale [92796]